← Evidence map

ReviewBreast cancer research : BCR2020

Triple-negative breast cancer molecular subtyping and treatment progress.

Li Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1,328 papers cite itlatest 60 shown

2020
…
2026
this paperpooled ittrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 32517735